CombiMatrix Corporation to Release Fourth Quarter and Year-End Financial Results on February 27, 2013
20 Febrero 2013 - 5:00AM
CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will
release its fourth quarter and year-end 2012 financial results on
Wednesday, February 27, 2013. Results will be released prior to
trading on that day.
A conference call has also been scheduled regarding CombiMatrix
Corporation's fourth quarter and year-end 2012 financial results.
The presentation and Q&A session will start at 8:00 a.m.
Pacific Time (11:00 a.m. Eastern) on February 27, 2013.
To attend the presentation by phone, dial 1-888-395-3227 for
domestic callers and 1-719-325-2215 for direct-dial or
international callers. To listen to the call via CombiMatrix's
website, go to www.combimatrix.com in the Investor/Events section
(http://investor.combimatrix.com/events.cfm).
A replay of the presentation will be available following the
presentation, either via the CombiMatrix website Investor/Events
section (http://investor.combimatrix.com/events.cfm) or by dialing
1-877-870-5176 for domestic callers or 1-858-384-5517 for
direct-dial international callers. When prompted, enter playback
pin number 3824098.
About CombiMatrix Corporation
CombiMatrix Corporation, through its wholly owned subsidiary,
CombiMatrix Molecular Diagnostics, Inc. (CMDX), is a molecular
diagnostics laboratory which offers DNA-based testing services to
the prenatal, pediatric and oncology markets. The Company performs
genetic testing utilizing Microarray, FISH, PCR and G-Band
Chromosome Analysis. CMDX offers prenatal and pediatric testing
services for the detection of abnormalities of genes at the DNA
level beyond what can be identified through traditional
technologies. CMDX was also the first commercial clinical
laboratory in the United States to make comprehensive DNA-based
genomic analysis of solid tumors, including breast, colon, lung,
prostate and brain tumors, available to oncology patients and
medical professionals. Additional information about CMDX is
available at www.cmdiagnostics.com or by calling
1-800-710-0624.
CONTACT: Company Contact:
R. Judd Jessup
President & CEO, CombiMatrix Corporation
Tel (949) 753-0624
Investor Relations Contact:
Matthew H. Clawson
Partner, Allen & Caron, Inc.
Tel (949) 474-4300
matt@allencaron.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Combimatrix Corp. (MM) (NASDAQ): 0 recent articles
Más de CombiMatrix Corporation Artículos de Noticias